Retail sale of other new goods
NORSEPHARMA AS
Revenue 2025
NOK 52,000
Operating profit
NOK 36,000
Equity
NOK 77,000
Incorporated
2018
Share capital
NOK 40,000
Key figures · 2024
Current ratio
9.79
Equity ratio
89.8%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 69.7% | |
| Net margin (%%) | 69.7% | |
| Return on assets (%%) | 41.7% | |
| Likviditet | ||
| Current ratio | 9.79 | |
| Working capital | 77k | |
| Soliditet | ||
| Equity ratio (%%) | 89.8% | |
| Debt-to-equity ratio | 0.11 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.